3 Reasons To Sell Barclays PLC But Buy Shawbrook Group PLC And OneSavings Bank PLC

There are three reasons why Shawbrook Group PLC (LON:SHAW) and OneSavings Bank PLC (LON: OSB) will outperform Barclays PLC (LON: BARC).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Barclays’ (LSE: BARC) outlook is improving and investors seem to be excited about the bank’s prospects. Indeed, year to date Barclays’ shares have outperformed the FTSE 100 by around 9%.

However, challenger banks Shawbrook (LSE: SHAW) and OneSavings (LSE: OSB) have notched up an even more impressive performance. So far this year the two challengers have racked up gains of 23% and 48% respectively. 

And there are three key reasons why this performance could be set to continue. 

Simple is best 

The banking sector’s increasing complexity is a key concern for the industry’s analysts. It has now become extremely difficult to understand and interpret the balance sheets of large financial institutions’. Even some of the world’s largest accounting firms and top City analysts have stated that banks are just becoming too complicated to understand.

Barclays is no exception. 

Barclays’ annual report now weighs in at a staggering 444 pages. The majority of the report is devoted to explaining the risks at the group’s investment bank, as well as the group’s exposure to exotic financial instruments. 

On the other hand, OneSavings and Shawbrook are very easy to understand.

Looking through OneSavings’ annual report, it’s easy to see how the company’s business works. There are around 20 pages of financial statements and the bank breaks down its loan book so investors can assess how much risk the lender is taking on.  

Similarly, Shawbrook’s annual report only extends to 70 pages. It’s easy to see that at the end of 2013 the group had taken £1.46bn of customer deposits, lent out £1.35bn, and had cash of £207m. 

The customer is always right

As part of its drive to cut costs, Barclays is overhauling many of its local branches. Counters are being removed and staff are being replaced by computers, which is alienating many of the bank’s customers.  

Luckily, for the likes of Shawbrook and OneSavings, this hands-off approach is pushing customers away from Barclays towards challenger banks that still place value on the client experience. 

Shawbrook is focused on lending to the small and medium sized business that has been turned down by traditional high street lenders. And since being set up during 2011, the bank has lent money to more than 60,000 SME’s and consumers. 

This approach attracted £1.4bn of new loans for the bank last year as UK businesses and consumers become more confident about trying new lenders. Shawbrook’s profit for the period jumped 192%. 

OneSavings’ speciality is mortgage lending, but the bank also targets SME’s. Targeting these two specialist sections of the market, with a different approach to mainstream lenders has helped the group triple pre-tax profits since 2013. 

Flexible model 

The third and final reason why Shawbrook and OneSavings are better picks than Barclays is their flexibility. 

Specifically, the two banks can adapt and change to market conditions faster than their larger, lumbering peer. The figures reveal all. 

Last year, Barclays’ return on equity — a key measure of bank profitability — was reported as 9.2%. The bank’s global footprint and complex business, which has become bogged down in regulation held down returns.

However, OneSavings and Shawbrook, both of which are smaller, and able to adjust quickly to changing consumer habits reported an ROE of 31% and 20% respectively for the same period. 

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »